Document Preview Unavailable
A randomized phase III study of docetaxel alone versus docetaxel plus S-1 in patients with previously treated non-small cell lung cancer: JMTO LC09-01
Atagi, Shinji; Daimon, Takashi; Okishio, Kyoichi; Komuta, Kiyoshi; Okano, Yoshio; et al. Thoracic Cancer Vol. 14, Iss. 29, (Oct 2023): 2941-2949.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library